Journal
/
Bioengineering
/
Prospektiv, randomiserad och kontrollerad studie av en human navelsträngsmesenkymal stamcellsinjektion för behandling av diabetiska fotsår…
JoVE Journal
Bioengineering
Bioengineering
JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다.
Prospektiv, randomiserad och kontrollerad studie av en human navelsträngsmesenkymal stamcellsinjektion för behandling av diabetiska fotsår
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/65045-v
•
04:09 min
•
March 3rd, 2023
Prospektiv, randomiserad och kontrollerad studie av en human navelsträngsmesenkymal stamcellsinjektion för behandling av diabetiska fotsår
March 3rd, 2023
•
Jingyu Zhang*1,2, Bingkun Zhao*1, Wuhan Wei*1,2, Dan Wang3,4,5, Haoyu Wang1,2, Aijun Zhang1, Changbo Tao1, Xueyang Li1, Qiang Li1, Peisheng Jin1
1Department of Plastic Surgery, Affiliated Hospital of Xuzhou Medical University, 2Graduate School, Xuzhou Medical University, 3Institute for Tissue Engineering and Regenerative Medicine, The Chinese University of Hong Kong, 4School of Biomedical Sciences, The Chinese University of Hong Kong, 5Center for Neuromusculoskeletal Restorative Medicine, Hong Kong Science Park
* These authors contributed equally
챕터
요약
Please note that all translations are automatically generated.
Click here for the English version.
Detta protokoll beskriver en prospektiv, randomiserad, kontrollerad klinisk studie som utvärderar en human navelsträngsmesenkymal stamcellsinjektion för behandling av kroniska diabetiska fotsår.